Christopher Campbell

Christopher Campbell

Company: Aurin Biotech

Job title: Chief Scientific Officer


Christopher J. Campbell is an entrepreneur and executive with over twenty years’ experience leading technology development programs and organizational innovation activities He currently oversees the R&D activities of Aurin Biotech Inc. (Vancouver, BC), a company founded by two of Canada’s most cited biomedical researchers.  Prior to joining AurinMr. Campbell served as the Chief Operating Officer of a nationally designated Centre of Excellence for Commercialization and Research. In this capacity he was responsible for day-to-day operations and the coordination of R&D and commercialization activities for a diverse range of technologies with applications in geophysical imaging, material science, nuclear security, and medicine.  In addition, he was instrumental in the formation of two research networks, including a national organization comprised of stakeholders dedicated to the mission of eradicating Alzheimer’s disease and related dementias. This experience has allowed him to develop Aurin’s early stage research assets to their current stage of development as well as participating in the strategic planning, and fundraising.  


Targeting the Distal Terminal Complement Cascade for the Treatment of Alzheimer’s Disease 5:15 pm

Download the Full Event Guide here to find out more Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.